Mass Gatherings – Neglected Factor In COVID Surges Seen In India, Pakistan and Neighbours 28/04/2021 Rahul Basharat Rajput & Mohammed Nadeem Chaudhry ISLAMABAD, PAKISTAN – Pakistan and its three estranged neighbouring countries – India, Iran and Afghanistan – are all struggling to restrain their large populations from attending deeply rooted and centuries-old cultural, religious festivals – so as to curb the spread of COVID-19 in the region. The cultural, political, and religious gatherings in all four developing […] Continue reading -> China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> Could A New COVID-19 Treatment Be The Answer To Combating The Pandemic In Africa? 27/04/2021 Geoffrey Kamadi NAIROBI – A new drug combination therapy to fight COVID-19, unveiled on Tuesday, will be tested in a multi-country clinical trial that is already ongoing in Africa. The drugs nitazoxanide and ciclesonide will be used in the ANTICOV clinical trials testing treatments for mild to moderate COVID cases across groups in 13 African countries. A […] Continue reading -> European Union Sues AstraZeneca Over Delayed Coronavirus Vaccine Deliveries 27/04/2021 Chandre Prince The European Union (EU) is suing coronavirus vaccine manufacturer AstraZeneca over an alleged breach of its vaccine supply contract and for not having a “reliable” plan to ensure timely deliveries. The European Commission – the EU’s executive branch – said the legal action emanates from a longstanding dispute over shortfall in vaccine deliveries. The 27 […] Continue reading -> Dealing With Ebola and Anthrax Prepared Africa for COVID-19 27/04/2021 Kerry Cullinan Africa’s brutal experiences battling Ebola and a range of other deadly diseases helped prepare health systems to deal with COVID-19. And by the time the SARS-CoV2 virus landed on the continent, its Centre for Disease Control (CDC) had already “established regional coordinating centres, increased lab capacity and unified surveillance networks”. The lessons in emergency response […] Continue reading -> Desperation In India As COVID-19 Rages – Critics Take To Social Media, While Vaccine Manufacturers Hike Prices 26/04/2021 Disha Shetty PUNE – Indian twitter for days has been a desperate space. There are appeals for oxygen cylinders, cries for funding to meet healthcare costs, and panic-stricken relatives scouting for hospital beds for their loved ones. Hospitals are now approaching the courts for help as they run out of oxygen. And even prominent lawyers and influencers […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> Could A New COVID-19 Treatment Be The Answer To Combating The Pandemic In Africa? 27/04/2021 Geoffrey Kamadi NAIROBI – A new drug combination therapy to fight COVID-19, unveiled on Tuesday, will be tested in a multi-country clinical trial that is already ongoing in Africa. The drugs nitazoxanide and ciclesonide will be used in the ANTICOV clinical trials testing treatments for mild to moderate COVID cases across groups in 13 African countries. A […] Continue reading -> European Union Sues AstraZeneca Over Delayed Coronavirus Vaccine Deliveries 27/04/2021 Chandre Prince The European Union (EU) is suing coronavirus vaccine manufacturer AstraZeneca over an alleged breach of its vaccine supply contract and for not having a “reliable” plan to ensure timely deliveries. The European Commission – the EU’s executive branch – said the legal action emanates from a longstanding dispute over shortfall in vaccine deliveries. The 27 […] Continue reading -> Dealing With Ebola and Anthrax Prepared Africa for COVID-19 27/04/2021 Kerry Cullinan Africa’s brutal experiences battling Ebola and a range of other deadly diseases helped prepare health systems to deal with COVID-19. And by the time the SARS-CoV2 virus landed on the continent, its Centre for Disease Control (CDC) had already “established regional coordinating centres, increased lab capacity and unified surveillance networks”. The lessons in emergency response […] Continue reading -> Desperation In India As COVID-19 Rages – Critics Take To Social Media, While Vaccine Manufacturers Hike Prices 26/04/2021 Disha Shetty PUNE – Indian twitter for days has been a desperate space. There are appeals for oxygen cylinders, cries for funding to meet healthcare costs, and panic-stricken relatives scouting for hospital beds for their loved ones. Hospitals are now approaching the courts for help as they run out of oxygen. And even prominent lawyers and influencers […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> Could A New COVID-19 Treatment Be The Answer To Combating The Pandemic In Africa? 27/04/2021 Geoffrey Kamadi NAIROBI – A new drug combination therapy to fight COVID-19, unveiled on Tuesday, will be tested in a multi-country clinical trial that is already ongoing in Africa. The drugs nitazoxanide and ciclesonide will be used in the ANTICOV clinical trials testing treatments for mild to moderate COVID cases across groups in 13 African countries. A […] Continue reading -> European Union Sues AstraZeneca Over Delayed Coronavirus Vaccine Deliveries 27/04/2021 Chandre Prince The European Union (EU) is suing coronavirus vaccine manufacturer AstraZeneca over an alleged breach of its vaccine supply contract and for not having a “reliable” plan to ensure timely deliveries. The European Commission – the EU’s executive branch – said the legal action emanates from a longstanding dispute over shortfall in vaccine deliveries. The 27 […] Continue reading -> Dealing With Ebola and Anthrax Prepared Africa for COVID-19 27/04/2021 Kerry Cullinan Africa’s brutal experiences battling Ebola and a range of other deadly diseases helped prepare health systems to deal with COVID-19. And by the time the SARS-CoV2 virus landed on the continent, its Centre for Disease Control (CDC) had already “established regional coordinating centres, increased lab capacity and unified surveillance networks”. The lessons in emergency response […] Continue reading -> Desperation In India As COVID-19 Rages – Critics Take To Social Media, While Vaccine Manufacturers Hike Prices 26/04/2021 Disha Shetty PUNE – Indian twitter for days has been a desperate space. There are appeals for oxygen cylinders, cries for funding to meet healthcare costs, and panic-stricken relatives scouting for hospital beds for their loved ones. Hospitals are now approaching the courts for help as they run out of oxygen. And even prominent lawyers and influencers […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Could A New COVID-19 Treatment Be The Answer To Combating The Pandemic In Africa? 27/04/2021 Geoffrey Kamadi NAIROBI – A new drug combination therapy to fight COVID-19, unveiled on Tuesday, will be tested in a multi-country clinical trial that is already ongoing in Africa. The drugs nitazoxanide and ciclesonide will be used in the ANTICOV clinical trials testing treatments for mild to moderate COVID cases across groups in 13 African countries. A […] Continue reading -> European Union Sues AstraZeneca Over Delayed Coronavirus Vaccine Deliveries 27/04/2021 Chandre Prince The European Union (EU) is suing coronavirus vaccine manufacturer AstraZeneca over an alleged breach of its vaccine supply contract and for not having a “reliable” plan to ensure timely deliveries. The European Commission – the EU’s executive branch – said the legal action emanates from a longstanding dispute over shortfall in vaccine deliveries. The 27 […] Continue reading -> Dealing With Ebola and Anthrax Prepared Africa for COVID-19 27/04/2021 Kerry Cullinan Africa’s brutal experiences battling Ebola and a range of other deadly diseases helped prepare health systems to deal with COVID-19. And by the time the SARS-CoV2 virus landed on the continent, its Centre for Disease Control (CDC) had already “established regional coordinating centres, increased lab capacity and unified surveillance networks”. The lessons in emergency response […] Continue reading -> Desperation In India As COVID-19 Rages – Critics Take To Social Media, While Vaccine Manufacturers Hike Prices 26/04/2021 Disha Shetty PUNE – Indian twitter for days has been a desperate space. There are appeals for oxygen cylinders, cries for funding to meet healthcare costs, and panic-stricken relatives scouting for hospital beds for their loved ones. Hospitals are now approaching the courts for help as they run out of oxygen. And even prominent lawyers and influencers […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Union Sues AstraZeneca Over Delayed Coronavirus Vaccine Deliveries 27/04/2021 Chandre Prince The European Union (EU) is suing coronavirus vaccine manufacturer AstraZeneca over an alleged breach of its vaccine supply contract and for not having a “reliable” plan to ensure timely deliveries. The European Commission – the EU’s executive branch – said the legal action emanates from a longstanding dispute over shortfall in vaccine deliveries. The 27 […] Continue reading -> Dealing With Ebola and Anthrax Prepared Africa for COVID-19 27/04/2021 Kerry Cullinan Africa’s brutal experiences battling Ebola and a range of other deadly diseases helped prepare health systems to deal with COVID-19. And by the time the SARS-CoV2 virus landed on the continent, its Centre for Disease Control (CDC) had already “established regional coordinating centres, increased lab capacity and unified surveillance networks”. The lessons in emergency response […] Continue reading -> Desperation In India As COVID-19 Rages – Critics Take To Social Media, While Vaccine Manufacturers Hike Prices 26/04/2021 Disha Shetty PUNE – Indian twitter for days has been a desperate space. There are appeals for oxygen cylinders, cries for funding to meet healthcare costs, and panic-stricken relatives scouting for hospital beds for their loved ones. Hospitals are now approaching the courts for help as they run out of oxygen. And even prominent lawyers and influencers […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Dealing With Ebola and Anthrax Prepared Africa for COVID-19 27/04/2021 Kerry Cullinan Africa’s brutal experiences battling Ebola and a range of other deadly diseases helped prepare health systems to deal with COVID-19. And by the time the SARS-CoV2 virus landed on the continent, its Centre for Disease Control (CDC) had already “established regional coordinating centres, increased lab capacity and unified surveillance networks”. The lessons in emergency response […] Continue reading -> Desperation In India As COVID-19 Rages – Critics Take To Social Media, While Vaccine Manufacturers Hike Prices 26/04/2021 Disha Shetty PUNE – Indian twitter for days has been a desperate space. There are appeals for oxygen cylinders, cries for funding to meet healthcare costs, and panic-stricken relatives scouting for hospital beds for their loved ones. Hospitals are now approaching the courts for help as they run out of oxygen. And even prominent lawyers and influencers […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Desperation In India As COVID-19 Rages – Critics Take To Social Media, While Vaccine Manufacturers Hike Prices 26/04/2021 Disha Shetty PUNE – Indian twitter for days has been a desperate space. There are appeals for oxygen cylinders, cries for funding to meet healthcare costs, and panic-stricken relatives scouting for hospital beds for their loved ones. Hospitals are now approaching the courts for help as they run out of oxygen. And even prominent lawyers and influencers […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> Posts navigation Older postsNewer posts